Skip to main content
Top
Published in: Journal of the International AIDS Society 4/2010

Open Access 01-12-2010 | Poster presentation

Efficacy and safety of TDF/FTC-containing, first-line HAART in clinical practice: 3-year data from the German outpatient cohort

Authors: J van Lunzen, G Fätkenheuer, T Lutz, S Klauke, S Mauss, H Knechten, P Braun, L Gallo, J Goldbach

Published in: Journal of the International AIDS Society | Special Issue 4/2010

Login to get access

Excerpt

First line HAART with tenofovir DF (TDF) and emtricitabine (FTC) in pivotal trials has been associated with high efficacy and good tolerability. However, real-life clinical practice often differs from clinical trials due to co-morbidities, co-infections, and less intensive clinical monitoring. …
Metadata
Title
Efficacy and safety of TDF/FTC-containing, first-line HAART in clinical practice: 3-year data from the German outpatient cohort
Authors
J van Lunzen
G Fätkenheuer
T Lutz
S Klauke
S Mauss
H Knechten
P Braun
L Gallo
J Goldbach
Publication date
01-12-2010
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1758-2652-13-S4-P12

Other articles of this Special Issue 4/2010

Journal of the International AIDS Society 4/2010 Go to the issue